These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 31897838)
1. Causes of secondary non-alcoholic fatty liver disease in non-obese children below 10 years. Mogahed EA; Sayed AA; Khalifa SE; El-Hennawy A; El-Raziky MS Eur J Pediatr; 2020 May; 179(5):719-726. PubMed ID: 31897838 [TBL] [Abstract][Full Text] [Related]
2. Education and imaging. Hepatology: Chanarin-Dorfman syndrome, a rare cause of fatty liver and steatohepatitis. Kazemi MH; Taghavi SA; Eshraghian A; Talebzadeh M; Hamidpour L J Gastroenterol Hepatol; 2015 May; 30(5):803. PubMed ID: 25865863 [No Abstract] [Full Text] [Related]
3. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease. Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023 [TBL] [Abstract][Full Text] [Related]
4. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627 [TBL] [Abstract][Full Text] [Related]
5. Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients. Huang Y; Gan Q; Lai R; Wang W; Guo S; Sheng Z; Chen L; Guo Q; Cai W; Wang H; Zhao G; Cao Z; Xie Q Front Cell Infect Microbiol; 2021; 11():733348. PubMed ID: 35111690 [TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic steatohepatitis in children. Nanda K Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336 [TBL] [Abstract][Full Text] [Related]
7. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. Adinolfi LE; Rinaldi L; Guerrera B; Restivo L; Marrone A; Giordano M; Zampino R Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231906 [TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients. Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071 [TBL] [Abstract][Full Text] [Related]
10. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients. Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434 [TBL] [Abstract][Full Text] [Related]
11. The anesthetic management of a patient with Dorfman-Chanarin syndrome. Beştaş A; Bolat E; Bayar MK; Erhan OL Middle East J Anaesthesiol; 2011 Oct; 21(3):437-40. PubMed ID: 22428507 [TBL] [Abstract][Full Text] [Related]
12. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874 [TBL] [Abstract][Full Text] [Related]
13. In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis. Africa JA; Behling CA; Brunt EM; Zhang N; Luo Y; Wells A; Hou J; Belt PH; Kohil R; Lavine JE; Molleston JP; Newton KP; Whitington PF; Schwimmer JB; Clin Gastroenterol Hepatol; 2018 Mar; 16(3):438-446.e1. PubMed ID: 28286193 [TBL] [Abstract][Full Text] [Related]